Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Ana Gleisner to Risk Factors

This is a "connection" page, showing publications Ana Gleisner has written about Risk Factors.

 
Connection Strength
 
 
 
0.278
 
  1. Halpern AL, Friedman C, Torphy RJ, Al-Musawi MH, Mitchell JD, Scott CD, Meguid RA, McCarter MD, Weyant MJ, Gleisner AL. Conversion to open surgery during minimally invasive esophagectomy portends worse short-term outcomes: an analysis of the National Cancer Database. Surg Endosc. 2020 08; 34(8):3470-3478.
    View in: PubMed
    Score: 0.061
  2. Catalano G, Alaimo L, Chatzipanagiotou OP, Ruzzenente A, Aucejo F, Marques HP, Lam V, Hugh T, Bhimani N, Kitago M, Endo I, Martel G, Popescu I, Cauchy F, Poultsides GA, Gleisner A, Pawlik TM. Analysis of a modified surgical desirability of outcome ranking (mDOOR) among patients undergoing surgery for Hepatocellular carcinoma. HPB (Oxford). 2025 Jun; 27(6):799-806.
    View in: PubMed
    Score: 0.022
  3. Catalano G, Alaimo L, Chatzipanagiotou OP, Ruzzenente A, Ratti F, Aldrighetti L, Marques HP, Cauchy F, Lam V, Poultsides GA, Hugh T, Popescu I, Alexandrescu S, Martel G, Kitago M, Endo I, Gleisner A, Shen F, Pawlik TM. Predicting the complexity of minimally invasive liver resection for hepatocellular carcinoma using machine learning. HPB (Oxford). 2025 Jun; 27(6):807-815.
    View in: PubMed
    Score: 0.022
  4. Altaf A, Akabane M, Khalil M, Rashid Z, Zindani S, Kawashima J, Ruzzenente A, Aldrighetti L, Bauer TW, Marques HP, Martel G, Popescu I, Weiss MJ, Kitago M, Poultsides G, Maithel SK, Lam V, Hugh T, Gleisner A, Sasaki K, Aucejo F, Pulitano C, Shen F, Cauchy F, Koerkamp BG, Endo I, Pawlik TM. Impact of intraoperative blood loss on postoperative morbidity after liver resection for primary and secondary liver cancer. HPB (Oxford). 2025 May; 27(5):660-669.
    View in: PubMed
    Score: 0.022
  5. Kawashima J, Endo Y, Woldesenbet S, Khalil M, Akabane M, Cauchy F, Shen F, Maithel S, Popescu I, Kitago M, Weiss MJ, Martel G, Pulitano C, Aldrighetti L, Poultsides G, Ruzzente A, Bauer TW, Gleisner A, Marques H, Groot Koerkamp B, Endo I, Pawlik TM. "Biological R2" resection for intrahepatic cholangiocarcinoma: identification of patients at risk for poor oncologic outcomes after curative-intent resection. HPB (Oxford). 2025 May; 27(5):619-629.
    View in: PubMed
    Score: 0.022
  6. Altaf A, Munir MM, Khan MMM, Rashid Z, Khalil M, Guglielmi A, Ratti F, Aldrighetti L, Bauer TW, Marques HP, Martel G, Alexandrescu S, Weiss MJ, Kitago M, Poultsides G, Maithel SK, Pulitano C, Lam V, Popescu I, Gleisner A, Hugh T, Shen F, Cauchy F, Koerkamp BG, Endo I, Pawlik TM. Machine learning based prediction model for bile leak following hepatectomy for liver cancer. HPB (Oxford). 2025 Apr; 27(4):489-501.
    View in: PubMed
    Score: 0.022
  7. Endo Y, Tsilimigras DI, Munir MM, Woldesenbet S, Guglielmi A, Ratti F, Marques HP, Cauchy F, Lam V, Poultsides GA, Kitago M, Alexandrescu S, Popescu I, Martel G, Gleisner A, Hugh T, Aldrighetti L, Shen F, Endo I, Pawlik TM. Machine learning models including preoperative and postoperative albumin-bilirubin score: short-term outcomes among patients with hepatocellular carcinoma. HPB (Oxford). 2024 Nov; 26(11):1369-1378.
    View in: PubMed
    Score: 0.021
  8. Altaf A, Endo Y, Munir MM, Khan MMM, Rashid Z, Khalil M, Guglielmi A, Ratti F, Marques H, Cauchy F, Lam V, Poultsides G, Kitago M, Popescu I, Martel G, Gleisner A, Hugh T, Shen F, Endo I, Pawlik TM. Impact of an artificial intelligence based model to predict non-transplantable recurrence among patients with hepatocellular carcinoma. HPB (Oxford). 2024 08; 26(8):1040-1050.
    View in: PubMed
    Score: 0.021
  9. Endo Y, Tsilimigras DI, Munir MM, Woldesenbet S, Yang J, Guglielmi A, Ratti F, Marques HP, Cauchy F, Lam V, Poultsides GA, Kitago M, Popescu I, Alexandrescu S, Martel G, Gleisner A, Hugh T, Aldrighetti L, Shen F, Endo I, Pawlik TM. Prognostic significance of postoperative complications for patients with hepatocellular carcinoma relative to alpha-feto protein and tumor burden score. HPB (Oxford). 2024 08; 26(8):998-1006.
    View in: PubMed
    Score: 0.021
  10. Bakos L, Wagner M, Bakos RM, Leite CS, Sperhacke CL, Dzekaniak KS, Gleisner AL. Sunburn, sunscreens, and phenotypes: some risk factors for cutaneous melanoma in southern Brazil. Int J Dermatol. 2002 Sep; 41(9):557-62.
    View in: PubMed
    Score: 0.019
  11. Hatzaras I, Gleisner AL, Pulitano C, Sandroussi C, Hirose K, Hyder O, Wolfgang CL, Aldrighetti L, Crawford M, Choti MA, Pawlik TM. A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer. HPB (Oxford). 2012 Aug; 14(8):532-8.
    View in: PubMed
    Score: 0.009
  12. Brand?o A, Fuchs SC, Gleisner AL, Marroni C, Zanotelli ML, Cantisani G. MELD and other predictors of survival after liver transplantation. Clin Transplant. 2009 Mar-Apr; 23(2):220-7.
    View in: PubMed
    Score: 0.007
  13. Asiyanbola B, Gleisner A, Herman JM, Choti MA, Wolfgang CL, Swartz M, Edil BH, Schulick RD, Cameron JL, Pawlik TM. Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio. J Gastrointest Surg. 2009 Apr; 13(4):752-9.
    View in: PubMed
    Score: 0.007
  14. Verdugo C, Pa?s E, Calvo C, Donoso J, Rojas N, Mart?nez C, Meza M, Asenjo S, Gleisner A, Gonz?lez MI. [Persistent microalbuminuria in insulin-dependent diabetics and cardiovascular risk factors]. Rev Med Chil. 1992 Jul; 120(7):755-60.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)